Disease Info Card

Muscular Atrophy, Spinal, Type Ii

Information about Muscular Atrophy, Spinal, Type Ii: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Muscular Atrophy, Spinal, Type Ii

Most recent studies have shown that Muscular Atrophy, Spinal, Type Ii shares some biological mechanisms with atrophy, congenital-abnormality, coughing, deglutition-disorders, dystrophy, flexed-fetal-attitude, hmn-(hereditary-motor-neuropathy)-proximal-type-i, hypoventilation, juvenile-spinal-muscular-atrophy, muscle-contracture, muscle-weakness, muscular-atrophy, muscular-dystrophy, muscular-dystrophy-duchenne, neuromuscular-diseases, pregnancy-complications, scoliosis-unspecified, spinal-muscular-atrophies-of-childhood, spinal-muscular-atrophy, weakness.

Among the many pathways, these few ones have gauged particular interests from scientists studying Muscular Atrophy, Spinal, Type Ii, and have been seen in publications frequently: Acrosome Reaction, Cell Death, Cellularization, Chromosome Segregation, Cytokinesis, Developmental Process, Gastric Emptying, Immune Response, Larval Development, Meiosis, Meiosis I, Mitosis, Muscle Atrophy, Nerve Maturation, Rna Interference, Sister Chromatid Cohesion, Sperm-egg Recognition, Sporulation, Swimming

Quite a number of genes have been found to play important roles in Muscular Atrophy, Spinal, Type Ii, such as CALR, CENPJ, CHKA, CHKB, CST7, DBNL, DMD, FDXR, NAIP, NDUFB6, SGCA, SMAD1, SMAD2, SMAD4, SMN1, SNRPN, STMN1, TPX2. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.